newsfilter
← Latest News
ACCESS Newswire·

Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock

BOULDER, CO / ACCESSWIRE / August 28, 2024 / Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid